» Articles » PMID: 30418123

The Frequency of Juvenile Spondyloarthropathies in Childhood Familial Mediterranean Fever

Overview
Specialty Rheumatology
Date 2018 Nov 13
PMID 30418123
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aim of this study is to evaluate the frequency of juvenile spondyloarthropathies (JSpA) in childhood familial Mediterranean fever (FMF) patients from a single tertiary centre. Additionally, we aimed to investigate the main clinical characteristics of FMF patients with coexistence of JSpA clinical features.

Methods: We evaluated 323 paediatric FMF patients who were followed at our clinic. All of the patients were evaluated by three different investigators (EO, DS, ET) for the presence of JSpA clinical signs, according to the recently proposed JSpA criteria. Patients preliminary diagnosed as FMF+JSpA were further evaluated by the experienced paediatric rheumatologist (OK) who made the final decision on the diagnosis of the patients.

Results: The female/male ratio was 1.13 (n =172/151). Preliminarily, 33 (10.2%) out of 323 paediatric FMF patients had been classified as FMF+JSpA. An experienced paediatric rheumatologist re-evaluated the classified patients and all of them were diagnosed as definitive FMF+JSpA. The M694V mutation was the most common mutation, seen in (n=18/32) (56.3%) FMF+JSpA and in (n=152/251) (61.1%) FMF patients without JSpA/JIA.

Conclusions: Apart from acute monoarthritis of the lower extremities, the chronic arthritis should be kept on mind among FMF patients with articular involvement. The JSpA should be considered in FMF patients with oligoarthritis, inflammatory back pain and enthesopathy complaints with onset over 6 years. Newly proposed JSpA criteria can be used to spondyloarthropathies in childhood FMF.

Citing Articles

Familial Mediterranean Fever in Childhood.

Kisla Ekinci R, Kilic Konte E, Akay N, Gul U Turk Arch Pediatr. 2024; 59(6):527-534.

PMID: 39540697 PMC: 11562618. DOI: 10.5152/TurkArchPediatr.2024.24188.


The Impact of Different MEFV Genotypes on Clinical Phenotype of Patients with Familial Mediterranean Fever: Special Emphasis on Joint Involvement.

Aslan E, Akay N, Gul U, Kilic Konte E, Gunalp A, Haslak F Eur J Pediatr. 2024; 183(10):4403-4410.

PMID: 39112805 PMC: 11413151. DOI: 10.1007/s00431-024-05716-y.


Genotype Mutations in Palestinian Children with Familial Mediterranean Fever: Clinical Profile, and Response to Colchicine Treatment: A Retrospective Cohort Study.

Shrateh O, Thalji M, Jobran A, Brakat A, Attia A, Abunejma F Mediterr J Rheumatol. 2023; 34(3):332-341.

PMID: 37941861 PMC: 10628868. DOI: 10.31138/mjr.20230912.stm.


Inflammatory comorbidities ın the largest pediatric Familial Mediterranean fever cohort: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).

Ozdel S, Coskuner T, Demirkan F, Torun R, Arslanoglu Aydin E, Baglan E Clin Rheumatol. 2023; 43(1):407-413.

PMID: 37926798 DOI: 10.1007/s10067-023-06802-6.


Mevalonate kinase gene polymorphisms in ankylosing spondylitis patients: A cross-sectional study.

Yildiz F, Dinkci S, Erken E Arch Rheumatol. 2023; 38(2):238-248.

PMID: 37680519 PMC: 10481690. DOI: 10.46497/ArchRheumatol.2023.9468.